If you are registered for the Conference, please sign in to benefit from additional features.

September 09th, 2026

10:00

11:30

Chairperson(s) : Thierry BRUE, Gérald RAVEROT

10:00

Que faire en cas de premier dépistage négatif à la recherche d'une cause génétique de tumeur hypophysaire agressive ou précoce ?

Pauline ROMANET, Marseille
10:30

Que faire au-delà du témozolomide en cas de tumeur hypophysaire agressive ?

Gérald RAVEROT, Lyon
11:00

Maladie de Cushing à image incertaine : faut-il opérer ?

Bertrand BAUSSART, Paris
11:30

12:15

Chairperson(s) : Philippe CHANSON, Nabila REKIB-MEJDOUB

11:30

Adénome thyréotrope géant : quand la collaboration endocrinologie-Neurochirurgie fait la différence

Fatma MNIF, Sfax, TUNISIA
11:45

Métamorphose phénotypique d’un Incidentalome hypophysaire non sécrétant en macroprolactinome géant et paradoxe radiobiologique : une double singularité évolutive

Khouloud BOUJELBEN, Sfax, TUNISIA
12:00

Maladie de Cushing et « kissing carotids » : un défi neurochirurgical face à une variante anatomique à haut risque

Ibticem BEN NACEF, Tunis, TUNISIA
13:15

14:00

Chairperson(s) : Davide CARVALHO, Marta KORBONITS, Albert BECKERS

13:15

Towards precision medicine in acromegaly: now and beyond

Manel PUIG DOMINGO
14:00

15:15

Chairperson(s) : Harriet SCHELLEKENS, Uberto PAGOTTO

14:00

Preclinical developments

Daniela LISKIEWICZ, , GERMANY
14:25

Non-obesity effects of GLP-1 agonists (smoking and alcohol abuse)

Kruse Klausen METTE, , DENMARK
14:50

Efficacy and side effects of GLP-1 agonists

Pagotto UBERTO, , ITALY
15:15

15:45
15:45

17:00

Chairperson(s) : Giovanna MANTOVANI, Jakob DAL

15:45

Fat and muscle fibrosis in acromegaly

Jens-Otto JORGENSEN, , DENMARK
16:10

Acromegaly and bone

Sabrina CHILOIRO, , ITALY
16:35

GH, IGF-I and cancer

Cesar BOGUSZEWSKI, , BRAZIL
17:00

18:00

Chairperson(s) : Davide CARVALHO, Krystallenia ALEXANDRAKI

17:00

Study on Resistant Prolactinoma

Kristallenia ALEXANDRAKI, , GREECE
17:04

Neuroendocrinology of Reproduction Study Group -Case studies presentation

Paraskevi XEKOUKI, , GREECE
17:08

Parasellar Lesions ENEA European Post Graduate Course

Josanne VASSALLO, , MALTA
17:08

GH Study Group

Alfonso SOTO, , SPAIN
17:12

ACTH Study Group

Mario DETOMAS, , GERMANY
17:16

TSH Study Group

Federico GATTO, , ITALY
17:20

Posterior Pituitary Study Group

Cihan ATILA, , SWITZERLAND
17:22

Plurihormonal Pathology Study Group

Antonio FUENTES-FAYOS, , SPAIN
17:26

Aggressive Pituitary Tumors and Pituitary Carcinomas Study Group

Mirela-Diana ILIE
18:00

18:30
18:30

19:30
20:00

21:00

September 10th, 2026

08:15

09:15
08:15

Genetics of acromegaly and pituitary gigantism

Pedro M. MARQUES, , PORTUGAL
08:30

09:15
08:30

What's new in pituitary apoplexy

Betina BIAGETTI, , SPAIN
08:30

Spatial transcriptomics and single cell analysis

Antonio FUENTES FAYOS, , SPAIN
09:15

09:45

Chairperson(s) : Marta KORBONITS

09:15

Olfactory food signals in the regulation of satiety and whole body metabolism

Sophie STECULORUM, , GERMANY
09:45

11:00
11:00

12:15

Chairperson(s) : Jerôme BERTHERAT, Sakina MHAOUTY-KODJA

11:00

11:00

Effects of exposure to endocrine disrupting chemicals on hypothalamus regulation of reproduction and appetite

Anne-Simone PARENT, , BELGIUM
11:25

Microbioma of the mother and development of hypothalamic circuits controlling appetite in the fetus

Sébastien BOURET
12:15

13:15
13:15

01:00
13:15

Browning and thermogenesis of adipose tissue

Saverio CINTI, , ITALY
13:15

Molecular imaging for pituitary and adrenal tumors

Völter FRIEDERIKE, , GERMANY
13:15

Hypogonadotropic hypogonadism

Luigi MAIONE
14:00

14:15

Chairperson(s) : Granata RICCARDA, Alvarez CLARA

14:00

POMC neurons: Not only satiety

Daniela COTA
14:25

Ghrelin, LEAP2 and food reward

Maximilian TUFVESSON-ALM, , IRELAND
14:50

Sympathetic Perineurial Cells: A New Interface for Energy Balance

Gitalee SARKER, , UNITED KINGDOM
15:15

15:15
16:15

17:15
16:15OP-001

Effects of a novel set of somatostatin/cortistatin analogues on pituitary neuroendocrine tumors

Federica MANGILI, Milan, ITALY
16:25OP-002

Integrating genomics, hormone measurements and functional validation in idiopathic hypogonadotropic hypogonadism: insights from a Maltese cohort

Clayton John AXIAK, Msida, MALTA
16:35OP-003

Pituitary Developmental Single-cell Mapping Identifies Markers of Heterogeneous High-risk USP8-wildtype Macroadenomas in Cushing’s Disease

Qilin ZHANG, Shanghai, CHINA
16:45OP-004

Senescence-associated secretory phenotype characterises aggressive non-functioning pituitary neuroendocrine tumours and is active in SOX2+ tumour stem cell compartments

James KAUFMAN-COOK, London, UNITED KINGDOM
16:55OP-005

MYC inhibition emerges as a potential therapy for fgSRL resistant patients in acromegaly

Paula DE PEDRO-CAMPOS, Badalona, SPAIN
17:05OP-006

Beyond Cortisol: Steroid Metabolomics after an Overnight 1‑mg Dexamethasone Test for the Differential Diagnosis of Hypercortisolism

Mario DETOMAS, Würzburg, GERMANY
17:15

18:30

Chairperson(s) : Mirela Diana ILIE, Giampaolo TRIVELIN

17:15

Transcriptomics of pituitary tumors: molecular classification and clinical implications

Fabio BIOLETTO, , ITALY
17:40

Advancing Pituitary Tumor Classifications Through Epigenomic Insights

Matthias DOTTERMUSCH, , GERMANY
18:05

Hyponatremia and the Brain

Julia BECK, , SWITZERLAND

September 11th, 2026

08:30

09:15
08:30

Pituitary incidentalomas

Niki KARAVITAKI, , UNITED KINGDOM
08:30

TSH-secreting adenomas

Andrea LANIA, , ITALY
08:30

Microglia and microbiota-gut-brain interaction

Lily KEANE, , IRELAND
09:15

10:15

Chairperson(s) : Riccarda GRANATA, Martin REINCKE

09:15

Basic

Raul LUQUE, , SPAIN
09:45

Clinical

Nienke BIERMASZ, , NETHERLANDS
10:15

11:15
11:15

11:45

Chairperson(s) : Castano JUSTO, Alexandraki KRYSTALLENIA

11:15

Integrating morpho-molecular landscapes to achieve a clinical classification of lung neuroendocrine tumours

Lynnette FERNANDEZ-CUESTA
11:45

11:45

Chairperson(s) : Justo CASTANO, Krystallenia ALEXANDRAKI

11:45

Defining the Cellular Landscape of Multifocal Small Intestine Neuroendocrine Tumors

Netta MÄKINEN, , UNITED STATES
12:10

Patient derived organoid models help to unveil translational discoveries in neuroendocrine neoplasms: the case of EGF

Talya DAYTON, , SPAIN
12:35

Current advances in the treatment of NETs: from targeted therapies to theranostic successes

Simona GLASBERG, , ISRAEL
13:00

14:00
14:00

14:45
14:00

Will steroidomics and AI replace dynamic testing in endocrine tumor diagnosis?

Georgiana CONSTANTINESCU, , GERMANY
14:00

Differential diagnosis of Cushing / pseudo-Cushing

Frederic CASTINETTI
14:00

AVP disorders

Julie REFARDT, , NETHERLANDS
14:45

16:00

Chairperson(s) : Katharina SCHILBACH, Chiara VILLA

14:45

Novel Mechanistic Insights in Craniopharyngiomas

Juan PEDRO MARTINÉZ BARBERA, , UNITED KINGDOM
15:10

Modern neuroradiological evaluation of craniopharyngiomas

Ruth PRIETO, , SPAIN
15:35

Surgical or medical treatment?

Emmanuel JOUANNEAU
16:00

16:30
16:30

17:30

Chairperson(s) : Peter WOLF, Nicoleta OLARESCU

16:30OP-013

A targeted proteomic approach reveals plasma biomarkers of active acromegaly

Nicoleta Cristina OLARESCU, Oslo, NORWAY
16:40OP-014

Pituitary gigantism is not only a younger form of growth hormone excess but also more aggressive phenotype with increased mortality: a comparison of 290 patients with pituitary gigantism and 2954 patients with acromegaly

Sonia KANIUKA-JAKUBOWSKA, Gdańsk, POLAND
16:50OP-015

Evidencing the safety and efficacy of pegvisomant for children and adolescents with acromegaly: a multicentre retrospective observational study

Kevin A. HUYNH, Cambridge, UNITED KINGDOM
17:00OP-016

Proteomic Analysis of GH-secreting and Non Functioning Pituitary Adenomas

Giordana SIRACUSANO, Messina, ITALY
17:10OP-017

Lifelong congenital untreated isolated GH deficiency does not alter human telomere length 

Júnia R.O.L. SCHWEIZER, Munich, GERMANY
17:20OP-018

Leptin in the regulation of neuroendocrine and immune-metabolic response to energy deprivation in health and disease

Konstantinos STEFANAKIS, Boston, UNITED STATES

Chairperson(s) : Antoine TABARIN, Marily THEODOROPOULOU

16:30OP-007

‘Block and replace’ atumelnant (CRN04894) and physiologic hydrocortisone replacement rapidly controls hypercortisolism in ACTH-dependent Cushing syndrome 

Alessandra CASAGRANDE
16:40OP-008

Circulating MicroRNA Signature in Inferior petrosal Sinus Sampling to Differentiate Patients with ACTH-Dependent Hypercortisolism.

Zhanna BELAYA, Moscow, RUSSIAN FEDERATION
16:50OP-009

Comparative Transcriptome Analysis of ACTH Secreting Pituitary Neuroendocrine Tumors (PitNET) According to USP8 Variant Status

Zhanna BELAYA, Moscow, RUSSIAN FEDERATION
17:00OP-010

Investigation of the safety, tolerability, pharmacokinetics, and efficacy of the novel anti-ACTH antibody asedebart in adults with Cushing’s disease: a Phase II, open-label, dose-titration trial

Heike BENECKE, Valby, DENMARK
17:10OP-011

Modeling and investigating SOX3 deletions associated with X-linked hypopituitarism using human iPSC-derived pituitary organoids

Giampaolo TRIVELLIN, Pieve Emanuele, ITALY
17:20OP-012

Loss of nuclear menin in non-MEN1 prolactinomas and sex differences: evidence from murine models and human tumors.

Graciela DIAZ-TORGA, Buenos Aires, ARGENTINA
17:30

18:45

Chairperson(s) : Dominique MAITER, Marta ARAUJO CASTRO

17:30

Specificities in the management of prolactinoma in children and adolescents

Joanne BLAIR, , UNITED KINGDOM
17:55

Should we change treatment paradigm in young women?

Iris Cm PELSMA, , NETHERLANDS
18:20

The different facets of prolactinoma in older patients

Stefan M CONSTANTINESCU, , BELGIUM

September 12th, 2026

09:30

10:00

Chairperson(s) : Martin REINCKE

09:30

Pituitary Surgery 2.0: How to approach invasive tumors

Lior GONEN, , ISRAEL
10:00

10:30

Chairperson(s) : Alberto PEREIRA

10:00

Yes

Daniela ESPOSITO, , SWEDEN
10:15

No

Peter KAMENICKY
10:30

11:00
11:00

12:15

Chairperson(s) : Pina KARDIOGLU, Frédéric CASTINETTI

11:00

Corticotroph Tumor development

Luis PEREZ-RIVAS, , GERMANY
11:25

Molecular Imaging in corticotroph tumors

Linus HABERBOSCH, , GERMANY
11:50

Medical treatment of Cushing's syndrome: New concepts, new drugs

Rosario PIVONELLO, , ITALY
12:15

12:30